Literature DB >> 21159212

Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample.

A Wilde1, B Meiser, P B Mitchell, D Hadzi-Pavlovic, P R Schofield.   

Abstract

BACKGROUND: Despite international concern about unregulated predictive genetic testing, there are surprisingly few data on both the determinants of community interest in such testing and its psychosocial impact.
METHOD: A large population-based public survey with community-dwelling adults (n=1046) ascertained through random digit dialling. Attitudes were assessed by structured interviews.
RESULTS: The study found strong interest in predictive genetic testing for a reported susceptibility to depression. Once the benefits and disadvantages of such testing had been considered, there was significantly greater interest in seeking such a test through a doctor (63%) compared to direct-to-consumer (DTC; 40%) (p<0.001). Personal history of mental illness [odds ratio (OR) 2.58, p<0.001], self-estimation of being at higher than average risk for depression (OR 1.92, p<0.001), belief that a genetic component would increase rather than decrease stigma (OR 1.62, p<0.001), and endorsement of benefits of genetic testing (OR 3.47, p<0.001) significantly predicted interest in having such a test.
CONCLUSIONS: Despite finding attitudes that genetic links to mental illness would increase rather than decrease stigma, we found strong community acceptance of depression risk genotyping, even though a predisposition to depression may only manifest upon exposure to stressful life events. Our results suggest that there will be a strong demand for predictive genetic testing. © Cambridge University Press 2010

Entities:  

Mesh:

Year:  2010        PMID: 21159212     DOI: 10.1017/S0033291710002394

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

Review 1.  Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.

Authors:  Sarah Hohmann; Nicoletta Adamo; Benjamin B Lahey; Stephen V Faraone; Tobias Banaschewski
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-04-08       Impact factor: 4.785

Review 2.  Ethics and neuropsychiatric genetics: a review of major issues.

Authors:  Steven K Hoge; Paul S Appelbaum
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-25       Impact factor: 5.176

3.  Ethical and professional challenges of genetic counseling - the case of Austria.

Authors:  Brigitte Gschmeidler; Magdalena Flatscher-Thoeni
Journal:  J Genet Couns       Date:  2013-06-01       Impact factor: 2.537

4.  Preferences regarding targeted education and risk assessment in people with a family history of major depressive disorder.

Authors:  Veronica Quinn; Bettina Meiser; Alex Wilde; Zoe Cousins; Kristine Barlow-Stewart; Philip B Mitchell; Peter R Schofield
Journal:  J Genet Couns       Date:  2014-01-10       Impact factor: 2.537

Review 5.  Direct-to-consumer personalized genomic testing.

Authors:  Cinnamon S Bloss; Burcu F Darst; Eric J Topol; Nicholas J Schork
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

6.  Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature.

Authors:  Lesley Goldsmith; Leigh Jackson; Anita O'Connor; Heather Skirton
Journal:  J Community Genet       Date:  2013-01-16

Review 7.  Direct-to-consumer genomic testing: systematic review of the literature on user perspectives.

Authors:  Lesley Goldsmith; Leigh Jackson; Anita O'Connor; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

Review 8.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

Review 9.  International Society of Psychiatric Genetics Ethics Committee: Issues facing us.

Authors:  Gabriel Lázaro-Muñoz; Maya Sabatello; Laura Huckins; Holly Peay; Franziska Degenhardt; Bettina Meiser; Todd Lencz; Takahiro Soda; Anna Docherty; David Crepaz-Keay; Jehannine Austin; Roseann E Peterson; Lea K Davis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-05-23       Impact factor: 3.568

10.  Interest, rationale, and potential clinical applications of genetic testing for mood disorders: a survey of stakeholders.

Authors:  Jessica A Erickson; Mildred K Cho
Journal:  J Affect Disord       Date:  2012-09-28       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.